article Open AccessTop 1% cited

Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma

Annals of Surgery · 2001 · Vol. 234(4) · pp. 507–519

William R. Jarnagin✉(Memorial Sloan Kettering Cancer Center)Yuman Fong✉Ronald P. DeMatteo✉Mithat GönenEdmund C. Burke✉Jessica Bodniewicz✉Michael Youssef✉David KlimstraLeslie H. Blumgart✉

View via DOI Publisher page

Abstract

By taking full account of local tumor extent, the proposed staging system for hilar cholangiocarcinoma accurately predicts resectability, the likelihood of metastatic disease, and survival. Complete resection remains the only therapy that offers the possibility of long-term survival, and hepatic resection is a critical component of the surgical approach.

Cholangiocarcinoma and Gallbladder Cancer Studies Viral-associated cancers and disorders Peptidase Inhibition and AnalysisMedicineConcomitantHepatectomySurgeryRadiologyResection

MeSH terms

AdultAgedAged, 80 and overBile Duct NeoplasmsBile Ducts, IntrahepaticFemaleFollow-Up StudiesHepatectomyHumansMagnetic Resonance ImagingMaleMiddle AgedNeoplasm StagingPreoperative CareProbability

Citations

1,354

FWCI

17.09

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Improvement in Perioperative Outcome After Hepatic Resection